Reuters -- St. Jude Medical Inc (STJ.N) reported better-than-expected quarterly profit and revenue on Thursday, partly helped by rival Boston Scientific Corp’s(BSX.N) one-month suspension of implantable heart defibrillators.
Reuters -- St. Jude Medical Inc (STJ.N) reported better-than-expected quarterly profit and revenue on Thursday, partly helped by rival Boston Scientific Corp’s(BSX.N) one-month suspension of implantable heart defibrillators.